DE60111192D1 - Verfahren zur herstellung von mikronisiertem kollagen, und therapeutische verwendungen - Google Patents

Verfahren zur herstellung von mikronisiertem kollagen, und therapeutische verwendungen

Info

Publication number
DE60111192D1
DE60111192D1 DE60111192T DE60111192T DE60111192D1 DE 60111192 D1 DE60111192 D1 DE 60111192D1 DE 60111192 T DE60111192 T DE 60111192T DE 60111192 T DE60111192 T DE 60111192T DE 60111192 D1 DE60111192 D1 DE 60111192D1
Authority
DE
Germany
Prior art keywords
production
collagen
therapeutic uses
powdered
micronized collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111192T
Other languages
English (en)
Other versions
DE60111192T2 (de
Inventor
Diego Furlan
Leonardo Cappelletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EURORES Srl
Original Assignee
EURORES Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EURORES Srl filed Critical EURORES Srl
Application granted granted Critical
Publication of DE60111192D1 publication Critical patent/DE60111192D1/de
Publication of DE60111192T2 publication Critical patent/DE60111192T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof
    • C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Cosmetics (AREA)
DE60111192T 2000-02-15 2001-02-07 Verfahren zur herstellung von mikronisiertem kollagen, und therapeutische verwendungen Expired - Lifetime DE60111192T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI000246 2000-02-15
IT2000MI000246A IT1317832B1 (it) 2000-02-15 2000-02-15 Procedimento per la preparazione di collagene micronizzato e sueapplicazioni terapeutiche.
PCT/EP2001/001283 WO2001060922A1 (en) 2000-02-15 2001-02-07 Process for the preparation of micronised collagen, and its therapeutic applications

Publications (2)

Publication Number Publication Date
DE60111192D1 true DE60111192D1 (de) 2005-07-07
DE60111192T2 DE60111192T2 (de) 2006-04-27

Family

ID=11444011

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60111192T Expired - Lifetime DE60111192T2 (de) 2000-02-15 2001-02-07 Verfahren zur herstellung von mikronisiertem kollagen, und therapeutische verwendungen
DE60136300T Expired - Lifetime DE60136300D1 (de) 2000-02-15 2001-02-07 Verfahren zur Herstellung von mikronisiertem Kollagen, und therapeutische Verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60136300T Expired - Lifetime DE60136300D1 (de) 2000-02-15 2001-02-07 Verfahren zur Herstellung von mikronisiertem Kollagen, und therapeutische Verwendungen

Country Status (9)

Country Link
US (2) US20030012741A1 (de)
EP (2) EP1263884B1 (de)
JP (1) JP2003523438A (de)
AT (1) ATE296859T1 (de)
CA (1) CA2395709C (de)
DE (2) DE60111192T2 (de)
ES (2) ES2313210T3 (de)
IT (1) IT1317832B1 (de)
WO (1) WO2001060922A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3805654B2 (ja) * 2001-08-29 2006-08-02 株式会社ネクスト 止血・癒着防止性のバイオポリマーの微細粒子
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
AU2003302906B2 (en) * 2002-12-11 2009-04-02 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
CA2554994C (en) * 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
CA2571981C (en) * 2004-07-09 2014-12-30 Ferrosan A/S Haemostatic composition comprising hyaluronic acid
CA2716872C (en) * 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9050070B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8784384B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Frozen compositions and array devices thereof
US9072799B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731841B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060931B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US9060926B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8793075B2 (en) * 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8551505B2 (en) * 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111831A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111836A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8545857B2 (en) * 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for administering compartmentalized frozen particles
US20100111841A1 (en) * 2008-10-31 2010-05-06 Searete Llc Compositions and methods for surface abrasion with frozen particles
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8603495B2 (en) * 2008-10-31 2013-12-10 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8551506B2 (en) * 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for administering compartmentalized frozen particles
US8731840B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060934B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111835A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8414356B2 (en) * 2008-10-31 2013-04-09 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8545855B2 (en) * 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US8762067B2 (en) 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US9050251B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8725420B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8545806B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US20100178038A1 (en) * 2009-01-12 2010-07-15 Mediatek Inc. Video player
US20130011451A1 (en) * 2011-07-06 2013-01-10 Diversified Glogal Technologies, Llc Footbed with non-denatured collagen
WO2013066812A1 (en) * 2011-10-31 2013-05-10 Shell Oil Company Hydrocarbon fluid compatible micronized polymers
JP6241624B2 (ja) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス 止血ペーストを収容する加圧容器
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
ES2709324T3 (es) 2013-05-15 2019-04-16 Euroresearch Srl Polvo de colágeno, composición y uso
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CN105828844B (zh) 2013-12-11 2019-09-27 弗罗桑医疗设备公司 包含挤出增强剂的干组合物
WO2016058612A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
US11913166B2 (en) 2015-09-21 2024-02-27 Modern Meadow, Inc. Fiber reinforced tissue composites
JP6971040B2 (ja) 2016-02-15 2021-11-24 モダン メドウ，インコーポレイテッド 複合バイオファブリケーテッド材料
EP3681950A4 (de) 2017-09-12 2021-06-16 Shilpa Medicare Limited Tranexamsäurespray für kniearthroplastik
AU2018253595A1 (en) 2017-11-13 2019-05-30 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
CA3097819A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
US11352497B2 (en) 2019-01-17 2022-06-07 Modern Meadow, Inc. Layered collagen materials and methods of making the same
US20220323549A1 (en) * 2019-09-12 2022-10-13 Global Health Solutions, Inc. Oil-based wound care compositions and methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2352894B2 (de) * 1973-10-22 1981-04-16 Aktieselskabet Niro Atomizer, Soeborg Verfahren zur Herstellung von Pulver aus Milch oder ähnlichen Flüssigkeiten
DK210679A (da) * 1979-05-22 1980-11-23 Niro Atomizer As Fremgangsmaade ved spraytoerring af et vaeskeformigt produkt og spraytoerringsanlaeg til brug ved udoevelse af fremgangsmaaden
DE3314903A1 (de) * 1982-04-28 1983-11-03 Edward Julius Bromyard Herefordshire Bals Spruehvorrichtung
DK157053B (da) * 1982-06-14 1989-11-06 Niro Atomizer As Fremgangsmaade til fremstilling af et agglomereret, pulverformet maelkeprodukt
EP0239970A3 (de) * 1986-03-31 1988-04-20 Toa Nenryo Kogyo Kabushiki Kaisha Zusammenstellung von Hydroxylapatit-Partikeln und deren Verwendung in einer Flüssigkeits-Chromatographie-Säule
IT1214505B (it) * 1987-03-12 1990-01-18 Gentili Ist Spa Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
JP2789115B2 (ja) * 1989-09-07 1998-08-20 株式会社高研 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
GB2274458A (en) * 1993-01-20 1994-07-27 Laporte B S D Limited Production of soluble collagen by hydrolysis and spray-drying
EP0729383B1 (de) * 1993-11-17 1999-07-07 Niro Holding A/S Verfahren und sprühtrocknungsgerät zum erzeugen von agglomeriertem pulver
JPH09510007A (ja) * 1994-03-11 1997-10-07 ニロ・ホールディング・アー／エス 噴霧乾燥装置
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
JPH0827035A (ja) * 1994-07-18 1996-01-30 Hokuyo Kk 新規な粉末コラーゲンおよびその製造方法
RO111787B1 (ro) * 1995-07-26 1997-01-30 Gabriel Lucian Radu Procedeu biotehnologic de obținere a hidrolizatelor de colagen

Also Published As

Publication number Publication date
ES2313210T3 (es) 2009-03-01
EP1263884B1 (de) 2005-06-01
EP1541634A1 (de) 2005-06-15
ES2243465T3 (es) 2005-12-01
US20070253912A1 (en) 2007-11-01
DE60111192T2 (de) 2006-04-27
CA2395709A1 (en) 2001-08-23
WO2001060922A1 (en) 2001-08-23
ITMI20000246A1 (it) 2001-08-15
JP2003523438A (ja) 2003-08-05
ITMI20000246A0 (it) 2000-02-15
IT1317832B1 (it) 2003-07-15
ATE296859T1 (de) 2005-06-15
EP1263884A1 (de) 2002-12-11
US20030012741A1 (en) 2003-01-16
EP1541634B1 (de) 2008-10-22
CA2395709C (en) 2009-09-22
DE60136300D1 (de) 2008-12-04

Similar Documents

Publication Publication Date Title
DE60111192D1 (de) Verfahren zur herstellung von mikronisiertem kollagen, und therapeutische verwendungen
ATE202940T1 (de) Mittel und methoden zur behandlung von plaque- krankheiten
DE60134003D1 (de) Verfahren und zusammensetzungen zur vermeidung und behandlung von anämie
ATE196507T1 (de) Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle
NO20024475L (no) Produksjon av rekombinante blodkoagulasjonsfaktorer i humane cellelinjer
DE60121928D1 (de) Verfahren zur herstellung von den trans-4-n-butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)-dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
DE69916856D1 (de) Micropartikeln zur verwendung in nadellosen injektion
RU94042240A (ru) Антагонисты рецепторов возбужденных аминокислот, способ получения, промежуточные соединения, фармацевтическая композиция
ATE137735T1 (de) Substituierte cyclohexan-derivate, verfahren zu ihrer herstellung und die anwendung der verbindungen zur behandlung von krankheiten
DE69828513D1 (de) Verfahren zur herstellung von nanokapseln des vesikulären typs
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
ATE306934T1 (de) Von willenbrand faktor (vwf) enthaltende zubereitung, verfahren zür herstellung von vwf enthaltenden zubereitungen und deren verwendung
DE69020391D1 (de) Thermoplastische Zusammensetzungen, die Polybenzoxazol-, Polybenzothiazol- und Polyimidazol-Gruppen enthalten, und Verfahren zur Herstellung von Formkörpern daraus.
UA60352C2 (uk) Синтетичні полісахариди та фармацевтична композиція, що їх містить
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
WO1997023507A3 (en) New form of amphiregulin, methods for producing and using the same and compositions comprising the same
PT769056E (pt) Variantes de gp350/220 sem processamento de excisao de introes ("splicing")
HU901636D0 (en) Process for producing new benzothio-pyranyl-amines and pharmaceutical preparatives containing them as active substance
DE69729201D1 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DE60231054D1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
KR950028787A (ko) 자연골치환형 인공골과 그 제조방법
DE69021557T2 (de) Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus.
ATE46181T1 (de) Derivat von keratin, verfahren zu dessen herstellung und dieses enthaltende behandlungszusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1263884

Country of ref document: EP

Representative=s name: FLEISCHER, GODEMEYER, KIERDORF & PARTNER, PATE, DE